Form 483

Omega Tech Labs, Inc. Form 483, 2016-08-25

FDA issued a Form 483 to Omega Tech Labs, Inc. on 2016-08-25 with 9 public-safe observations.

483· Form 483 issuedHuman Drugs9 observations

Omega Tech Labs, Inc. · Boise, United States · Issued August 25, 2016

Overview

  • 9 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

25 Aug 2016
21 CFR 211.113(a)

Procedures for non-sterile drug products

Cited by Christopher R Czajka

25 Aug 2016
21 CFR 211.125(a)

Strict control not exercised over labeling issued

Cited by Christopher R Czajka

25 Aug 2016
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Christopher R Czajka

25 Aug 2016
21 CFR 211.165(a)

Testing and release for distribution

Cited by Christopher R Czajka

25 Aug 2016
21 CFR 211.166(b)

Accelerated stability studies

Cited by Christopher R Czajka

Inspected site

OTOmega Tech Labs, Inc.Boise, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(a)Cited across public-safe Form 483 observations1x
21 CFR 211.125(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(a)Cited across public-safe Form 483 observations1x
21 CFR 211.166(b)Cited across public-safe Form 483 observations1x
21 CFR 211.188(a)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.80(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere